Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data

NIH RePORTER · NIH · R01 · $541,133 · view on reporter.nih.gov ↗

Abstract

Project Summary Non-invasive detection of cell-free DNA(cfDNA) promises to impact clinical regimens of a wide range of diseases, e.g. prenatal conditions, cancer, transplantation, autoimmune disease, trauma, and cardiovascular disease. While this field is emerging as one of the most promising and exciting areas of medicine, few bioinformatics tools are available to facilitate the information extraction from cfDNA sequencing data, although cfDNA data possesses many unique properties. In this proposal, we aim to generate a suite of computational methods facilitating the analysis and interpretation of cfDNA sequencing data, and demonstrate its utilities in cancer detection and characterization. Specifically, we will develop computational methods for the following applocations: (1) Ultra-sensitively detect and locate multiple types of cancer using cfDNA methylome; (2) Detect Copy Number Variation (CNV) in cfDNA sequencing data; (3) Annotate Single Nucleotide Variations (SNV) in cfDNA sequencing data. These computational tools will be validated with cfDNA samples collected from a cohort of lung cancer patients participating in an immunotherapy clinical trial, a repository of blood samples from patients with different types of cancer, and a cohort of liver cancer patients. Although we use cancer as the main context for developing these applications, many of the methods can be adapted to other diseases, e.g. prenatal diagnosis and organ transplant monitoring. We expect that the above open-source tools will significantly facilitate cfDNA- based disease diagnosis and monitoring. 1

Key facts

NIH application ID
10476324
Project number
5R01CA246329-04
Recipient
UNIVERSITY OF CALIFORNIA LOS ANGELES
Principal Investigator
Steven M. Dubinett
Activity code
R01
Funding institute
NIH
Fiscal year
2022
Award amount
$541,133
Award type
5
Project period
2019-09-01 → 2023-08-31